Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.
about
Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expressionTwenty Years of PSA: From Prostate Antigen to Tumor MarkerHigher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistanceThe androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerThe new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulationEnzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitorsThe emerging roles of human tissue kallikreins in cancerHuman tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progressionExpression and characterization of trypsinogen produced in the human male genital tractThe cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3Design of synthetic hexapeptide substrates for prostate-specific antigen using single-position minilibraries.Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates.Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues.Expression, purification, and characterization of active recombinant prostate-specific antigen in Pichia pastoris (yeast).Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literatureInsulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.Production of active mammalian and viral proteases in bacterial expression systems.The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.Human tissue kallikreins: a new enzymatic cascade pathway?Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.Human tissue kallikreins and testicular cancer.The role of prostate-specific antigen in the clinical evaluation of prostatic disease.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.Recombinant kallikrein expression: site-specific integration for hK6 production in human cells.The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.Kallikreins - The melting pot of activity and functionGenome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretionsActivation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axisDevelopment of peptides specifically modulating the activity of KLK2 and KLK3.Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?Antiangiogenic properties of prostate-specific antigen (PSA).From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.
P2860
Q22009031-194445D9-A29D-4D44-BAF4-AE9CD99198A7Q24564782-D319CB6E-CDA6-40C1-9D78-40CB47BC5FCBQ24642804-0E3A744E-7847-4B1D-8661-DBAD3F699469Q24646770-DA06D51E-2120-40ED-8562-864AF4DEE3C1Q28118219-8FE654CA-5CC9-48E9-A1A8-12EDA0843A8FQ28140072-8BBD5889-97C7-4550-B10D-43B8B6D392FBQ28290701-EA913C23-E83B-4794-AD24-821C62E4857FQ28300449-7C405061-8363-4013-AC97-BAC1BB6FA10EQ28345000-277C80B4-EA8F-4B5A-8F0D-A39225B4547CQ28616503-8E10C29E-A509-4CB1-AD45-EA088D42B2BAQ30813415-01438E92-3F2C-449C-BEB3-FC54B1A5F45EQ31036435-75C2CADF-95E3-4F4C-A378-656B3A500F92Q31044291-B5C7C971-60A5-4E94-81C3-C1AFE9F62197Q31910018-7AFAA3B8-BD23-475B-A800-9EEAC3C427B9Q32162109-4CA8CA52-0E00-4CDE-8156-3D94895B4CB8Q33526707-065B66A5-5E67-40D8-AC47-36FE45FD30AEQ33726814-2E3D417E-B169-4EE7-B825-D38A21A449E2Q33884420-77571D41-2E70-42C1-83D6-22DB0EC8BA7DQ33911725-227D8BA1-ABCE-483A-86C0-D590961AE714Q33947270-C828E8C0-DB49-4766-8ED3-321AA095D021Q34187840-DF3710BB-D06E-46CB-9C08-914A64D79385Q34447102-6402CBE0-95F0-4FA0-8F61-80DA17FF5E93Q35000702-DEB74EDA-6B3E-4827-891A-685D47D48FF9Q35048230-3DD6CC6C-D7BF-446F-BF8A-0924D8E47C1BQ35129502-F3097D3A-08FB-484A-BAC7-06370562F9AAQ35685854-58766EED-91C7-4DC9-80A4-704A8A4CD09AQ35861497-EE2A0D74-D777-4C76-8CBE-4017D16EE044Q36266738-22411F36-188F-4A69-B9FA-DABFD24490D3Q36414170-779A7B6C-C89C-4554-9306-EF982CD48937Q36442339-88403940-E9F3-4A93-B7F3-D5AE169C1190Q36519374-141EFE32-5B9B-424A-9BC2-2B4FFECEA27AQ36519383-F555B91D-2CF9-4EA4-BE02-72530525EBA1Q36563056-A80D19F5-9729-447C-9913-F2760B3AF3E8Q36567585-B5E146C0-14C2-4350-92CF-77096AD6F973Q36621078-8109939E-3D6C-4495-AEDE-4D8BEC343836Q36962704-C3355FD4-CBC5-4D28-BED3-402A634B8392Q37216674-E2BCBDBA-5CC8-472E-BF4A-D974FAABB435Q37290033-A7A009B1-D0EE-42F0-8E63-724B3CD910F1Q37529537-7B2B6EC9-64C2-4680-95F3-727C3EB87C3EQ38023597-66E49AE9-6109-4B6C-8B52-6096733F7433
P2860
Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Characterization of the precur ...... by human glandular kallikrein.
@en
Characterization of the precur ...... by human glandular kallikrein.
@nl
type
label
Characterization of the precur ...... by human glandular kallikrein.
@en
Characterization of the precur ...... by human glandular kallikrein.
@nl
prefLabel
Characterization of the precur ...... by human glandular kallikrein.
@en
Characterization of the precur ...... by human glandular kallikrein.
@nl
P2093
P2860
P356
P1476
Characterization of the precur ...... by human glandular kallikrein.
@en
P2093
P2860
P304
21582-21588
P356
10.1074/JBC.272.34.21582
P407
P577
1997-08-01T00:00:00Z